December 7, 2022
Loading...
You are here:  Home  >  'Atara Biotherapeutics'
Latest

Atara shares drop after larger Q3 loss than expected

By   /  Tuesday, November 8th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Tri-County Public Companies, Ventura County  /  Comments Off on Atara shares drop after larger Q3 loss than expected

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Atara treatment nears European approval

By   /  Monday, October 31st, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, middle, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Atara treatment nears European approval

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Atara announces plan to cut workforce by 20%

By   /  Tuesday, August 9th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, left, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Atara announces plan to cut workforce by 20%

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Atara reports Q1 loss as it pursues EU and FDA approvals

By   /  Wednesday, May 11th, 2022  /  Banking & Finance, Earnings, Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Tri-County Public Companies, Ventura County  /  Comments Off on Atara reports Q1 loss as it pursues EU and FDA approvals

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Sale of Atara’s Thousand Oaks property will fund company’s drug development through 2023

By   /  Thursday, April 14th, 2022  /  Health Care & Life Science, Latest news, Regions, Subscriber content, Top Stories, Ventura County  /  Comments Off on Sale of Atara’s Thousand Oaks property will fund company’s drug development through 2023

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

In Thousand Oaks, biotech execs discuss industry’s ‘rising tide,’ lament area’s lack of housing

By   /  Friday, April 8th, 2022  /  Health Care & Life Science, Latest news, Regions, Top Stories, Top Story, Ventura County  /  Comments Off on In Thousand Oaks, biotech execs discuss industry’s ‘rising tide,’ lament area’s lack of housing

In a dark period for the Ventura County economy, immediately before and during the COVID-19 pandemic, the biotechnology sector in the Conejo Valley has been a bright spot. The sector has grown in jobs, economic output and new businesses since 2019, even when the county as a whole has not, according to data presented on Read More →

Latest

Atara closes $100M sale of Thousand Oaks facility

By   /  Wednesday, April 6th, 2022  /  Banking & Finance, Health Care & Life Science, Latest news, Regions, Tri-County Public Companies, Ventura County  /  Comments Off on Atara closes $100M sale of Thousand Oaks facility

Atara Biotherapeutics, a drugmaker based in South San Francisco with a large presence in Thousand Oaks, announced April 4 that its cell therapy manufacturing facility in Thousand Oaks was purchased by Fujifilm Corp. for $100 million. The deal was first announced in January and is part of a long-term strategic supply agreement between Atara and Read More →